Rescue medications for sacituzumab tirumotecan clinical trials

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

This study is testing a new medicine, Sacituzumab Tirumotecan (Sac-TMT), for advanced bladder cancer that has worsened after other treatments. Researchers want to see if Sac-TMT helps people live longer compared to standard chemotherapy.